Free Trial
OTCMKTS:BSEM

BioStem Technologies (BSEM) Stock Price, News & Analysis

BioStem Technologies logo
$13.65 +0.55 (+4.20%)
As of 06/5/2025 03:56 PM Eastern

About BioStem Technologies Stock (OTCMKTS:BSEM)

Key Stats

Today's Range
$12.70
$14.34
50-Day Range
$7.58
$15.30
52-Week Range
$6.77
$28.26
Volume
152,940 shs
Average Volume
68,590 shs
Market Capitalization
$228.01 million
P/E Ratio
20.07
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Receive BSEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioStem Technologies and its competitors with MarketBeat's FREE daily newsletter.

BSEM Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
BSEM Expands Margins and Grows Business
See More Headlines

BSEM Stock Analysis - Frequently Asked Questions

BioStem Technologies' stock was trading at $13.84 on January 1st, 2025. Since then, BSEM shares have decreased by 1.4% and is now trading at $13.65.
View the best growth stocks for 2025 here
.

BioStem Technologies, Inc. (OTCMKTS:BSEM) announced its quarterly earnings results on Monday, May, 12th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $1.25 by $1.08. The firm earned $72.53 million during the quarter, compared to analysts' expectations of $101.20 million.
Read the conference call transcript
.

Shares of BSEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioStem Technologies investors own include NVIDIA (NVDA), Tesla (TSLA), Broadcom (AVGO), Advanced Micro Devices (AMD), SoFi Technologies (SOFI) and Energy Transfer (ET).

Company Calendar

Last Earnings
5/12/2025
Today
6/05/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BSEM
Previous Symbol
OTCMKTS:BSEM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
19.26
Forward P/E Ratio
9.29
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$16.68 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$218.82 million
Optionable
N/A
Beta
-0.10
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (OTCMKTS:BSEM) was last updated on 6/6/2025 by MarketBeat.com Staff
From Our Partners